Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-296635
Filing Date
2023-12-15
Accepted
2023-12-15 16:08:29
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d888170ds3.htm S-3 357790
2 EX-4.4 d888170dex44.htm EX-4.4 296272
3 EX-5.1 d888170dex51.htm EX-5.1 39550
4 EX-5.2 d888170dex52.htm EX-5.2 24817
5 EX-23.1 d888170dex231.htm EX-23.1 3044
6 EX-FILING FEES d888170dexfilingfees.htm EX-FILING FEES 43856
7 GRAPHIC g888170g08p55.jpg GRAPHIC 1840
8 GRAPHIC g888170g1209034117217.jpg GRAPHIC 6396
9 GRAPHIC g888170g59y36.jpg GRAPHIC 13350
10 GRAPHIC g888170g66z77.jpg GRAPHIC 6555
11 GRAPHIC g888170g77p76.jpg GRAPHIC 2901
12 GRAPHIC g888170img007.jpg GRAPHIC 1017
  Complete submission text file 0001193125-23-296635.txt   811299
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276069 | Film No.: 231490368
SIC: 2833 Medicinal Chemicals & Botanical Products